Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients
This study is a randomized, double-blind, controlled trial exploring the effects of long-term taVNS intervention in patients with early-stage Parkinson's disease.
Age 55-75 years. [+4]
Patients with cognitive impairment (MMSE < 24 and/or MoCA < 26) or mental illnes... [+15]